tradingkey.logo

LeMaitre Vascular Inc

LMAT
查看詳細走勢圖
84.510USD
-0.450-0.53%
收盤 12/22, 16:00美東報價延遲15分鐘
1.92B總市值
35.80本益比TTM

LeMaitre Vascular Inc

84.510
-0.450-0.53%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-0.53%

5天

+2.10%

1月

-3.89%

6月

+3.34%

今年開始到現在

-8.28%

1年

-8.26%

查看詳細走勢圖

TradingKey LeMaitre Vascular Inc股票評分

單位: USD 更新時間: 2025-12-19

操作建議

LeMaitre Vascular Inc當前公司基本面數據相對非常健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名35/208位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價104.33。中期看,股價處於平穩狀態。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

LeMaitre Vascular Inc評分

相關信息

行業排名
35 / 208
全市場排名
110 / 4582
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 11 分析師
買入
評級
104.333
目標均價
+25.81%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

LeMaitre Vascular Inc亮點

亮點風險
LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and other specialties, such as cardiac surgeons, general surgeons, and neurosurgeons. Its portfolio of product lines is used to treat vascular disease, which used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy and occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. Its principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. Its product offerings are sold primarily in the United States, Europe, Canada, and Asia Pacific.
業績高增長
公司營業收入穩步增長,連續3年增長36.01%
利潤高增長
公司淨利潤處於行業前列,最新年度總收入219.86M美元
高分紅
公司屬於高分紅公司,最新股息支付率32.65%
穩定分紅
公司5年內持續分紅,最新股息支付率32.65%
估值低估
公司最新PE估值35.99,處於3年歷史低位
機構減倉
最新機構持股21.34M股,環比減少5.36%
詹姆斯·西蒙斯持倉
明星投資者詹姆斯·西蒙斯持倉,最新持倉180.60K股
活躍度增加
近期活躍度增加,過去20天平均換手率0.42

LeMaitre Vascular Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

LeMaitre Vascular Inc簡介

LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and other specialties, such as cardiac surgeons, general surgeons, and neurosurgeons. Its portfolio of product lines is used to treat vascular disease, which used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy and occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. Its principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. Its product offerings are sold primarily in the United States, Europe, Canada, and Asia Pacific.
公司代碼LMAT
公司LeMaitre Vascular Inc
CEOLemaitre (George W)
網址https://www.lemaitre.com/

常見問題

LeMaitre Vascular Inc(LMAT)的當前股價是多少?

LeMaitre Vascular Inc(LMAT)的當前股價是 84.510。

LeMaitre Vascular Inc 的股票代碼是什麼?

LeMaitre Vascular Inc的股票代碼是LMAT。

LeMaitre Vascular Inc股票的52週最高點是多少?

LeMaitre Vascular Inc股票的52週最高點是105.550。

LeMaitre Vascular Inc股票的52週最低點是多少?

LeMaitre Vascular Inc股票的52週最低點是71.420。

LeMaitre Vascular Inc的市值是多少?

LeMaitre Vascular Inc的市值是1.92B。

LeMaitre Vascular Inc的淨利潤是多少?

LeMaitre Vascular Inc的淨利潤為44.04M。

現在LeMaitre Vascular Inc(LMAT)的股票是買入、持有還是賣出?

根據分析師評級,LeMaitre Vascular Inc(LMAT)的總體評級為買入,目標價格為104.333。

LeMaitre Vascular Inc(LMAT)股票的每股收益(EPS TTM)是多少

LeMaitre Vascular Inc(LMAT)股票的每股收益(EPS TTM)是2.361。
KeyAI